Skip to main content

Table 4 Time for administration of the ROSA and four other scales

From: Validation of the relevant outcome scale for Alzheimer's disease: a novel multidomain assessment for daily medical practice

Administration

Time (minutes)

  

Early stage

Middle stage

Late stage

Overall

ROSA

BL

13.6 (7.27)

15.5 (6.72)

14.4 (5.50)

14.5 (6.82)

 

W12

13.2 (5.48)

15.3 (6.54)

14.3 (4.79)

14.3 (5.93)

ADAS-cog

BL

24.7 (7.39)

25.2 (7.51)

-

25.2 (7.51)

 

W12

22.7 (7.45)

25.7 (8.06)

-

24.3 (7.89)

SIB

BL

-

24.8 (9.08)

29.0 (10.21)

26.3 (9.89)

 

W12

-

24.5 (10.20)

26.4 (11.02)

25.4 (10.58)

NPI

BL

14.3 (6.60)

15.9 (11.87)

18.2 (7.81)

15.6 (9.54)

 

W12

13.7 (7.20)

13.5 (6.46)

17.0 (8.40)

14.1 (7.19)

DAD

BL

10.8 (6.20)

11.5 (5.28)

12.4 (5.89)

11.4 (5.77)

 

W12

9.9 (4.66)

11.3 (4.84)

11.6 (6.00)

10.8 (5.00)

  1. Data presented as mean (standard deviation). ADAS-cog, Alzheimer's Disease Assessment Scale - cognitive subscale; BL, baseline; DAD, Disability Assessment for Dementia; NPI, Neuropsychiatric Inventory; ROSA, Relevant Outcome Scale for Alzheimer's Disease; SIB, Severe Impairment Battery; W12, week 12 after baseline.